Physician Lab Referral Bonuses: When Productivity Pays for Lab Referrals

A physician lab referral bonus can violate the Stark Law when it pays for laboratory referrals through a compensation arrangement that fails the law’s exceptions. The revealing detail is what earns the bonus: work the physician performs, tests the physician orders, or profit the laboratory makes from those orders. If you calculate the bonus, process the testing claims or work beside the ordering physician, you may see how a clinical decision becomes a payment back to the person making it.

How Does the Stark Law Affect Physician Self-Referrals?

The Stark Law bars a physician from referring Medicare patients for covered services to a business in which the physician or an immediate family member has a financial stake, unless an exception applies. The business also cannot bill for services from those prohibited referrals. Clinical laboratory services are among the designated health services that bring a lab bonus into the physician self-referral question.

The financial relationship can be ownership, an investment or compensation. An employed physician’s bonus therefore belongs in the analysis just as an owner’s profit distribution does. The Centers for Medicare & Medicaid Services explanation of the self-referral law puts the financial relationship, the referral and the resulting bill together. For an insider, the useful connection runs from the test order to laboratory receipts and then to the compensation calculation.

The physician kickback question brings a separate law into view. The Anti-Kickback Statute addresses knowing and willful payments or benefits offered or received for federally payable referrals or orders. Stark’s referral and billing rules focus on the financial relationship, without requiring proof that someone knowingly and willfully paid for referrals. We examine what each participant supplied, received and understood, together with the claims the arrangement generated.

What the Productivity Formula Actually Counts

A physician productivity bonus structure can reward services the physician personally performs. A payment calculated from the profit on referred laboratory tests raises a different question about what the physician did to earn it.

That distinction has a practical accounting basis. Imaging separates the physician’s interpretation and written report from the technical resources used to produce the image. Most routine clinical laboratory testing uses the Clinical Laboratory Fee Schedule, while anatomic pathology can have separate physician-fee components.

A physician’s earnings can also rise through a share of the facility’s profit. The Robert Wood Johnson Foundation’s 2008 research synthesis, Physician Self-Referral and Physician-Owned Specialty Facilities, explains why that source of income has a different incentive from a professional fee:

The report’s examples concern facilities and imaging. They help explain why a compensation review reaches beyond the physician’s own work: the referral can produce another stream of earnings. In the laboratory cases, the government’s allegations make that connection concrete, down to the profit percentage and the deductions used to calculate a bonus.

Lab Bonuses Tied to the Physician’s Orders

Physician Partners of America and the Testing-Profit Share

Physician Partners of America allegedly paid its physician employees 40% of the profits from presumptive urine drug testing to encourage those orders. The Justice Department’s April 2022 settlement announcement describes the percentage as part of its Stark Law allegations. The company, its founder and its former chief medical officer agreed to a $24.5 million settlement covering unnecessary testing, improper physician payments and other alleged conduct.

The settlement agreement describes the compensation allegation more precisely: physicians received a percentage of net profit from qualitative urine drug testing orders attributable to them. It identifies Medicare claims arising from those arrangements between October 2015 and November 2021. The ordering physician’s attributed testing profit was the compensation input the government challenged.

The government also alleged that the company required multiple urine tests at once, without reviewing the initial results to decide whether additional testing was needed. The government alleged that its toxicology laboratory then billed federal health care programs for the highest-level testing. The agreement further alleged that medical assistants carried out a testing protocol without treating-physician review.

That joins the compensation decision to the clinical workflow. We see the absurdity: under the alleged arrangement, the doctor earned a cut from testing while initial results went unreviewed before more tests were ordered. Taxpayers funded the tests. The person calculating testing profits and the assistant carrying out the protocol would see different parts of the same alleged arrangement.

Northwest and the Bonus After Costs and Fees

Northwest Anesthesiology and Pain Services reported approximately $1.8 million in bonus payments from January 2019 through December 2021 after an internal investigation. According to the Justice Department’s January 2025 announcement, Northwest claimed that its management contractor instructed the billing company to calculate bonuses from lab referrals minus costs, fees and expenses. Its agreements instead called for bonuses based on the pain practices’ productivity.

The contractor had authority over compensation and discretionary bonuses for Northwest’s independently contracted pain management practices. Northwest suspected that the calculation increased total collections, which also determined the contractor’s management fee. On that account, the arrangement rewarded the recipient practices through lab bonuses and benefited the manager through the collections used to set her fee.

Northwest agreed to pay $999,999 to resolve the government’s allegations concerning Medicare claims and improper financial relationships with the pain practices. That settlement was smaller than the bonuses Northwest reported paying. Northwest disclosed the conduct to the U.S. Attorney’s Office for the Southern District of Texas, which investigated with assistance from the Health and Human Services inspector general.

The billing instructions are central to this account. The contract described productivity, while the calculation allegedly followed referrals after deductions. For someone inside a practice, the discrepancy between the promised formula and the one the billing company actually used can explain far more than the heading on the compensation agreement.

Lab Profit Splits Changed in 2022

For a physician bonus based on in-office laboratory profit, the pool of money matters as much as the formula dividing it. The Centers for Medicare & Medicaid Services’ group-practice profit-sharing provisions effective January 1, 2022 define overall profits as profits from all designated health services of a component containing at least five physicians. If the entire group has fewer than five physicians, the definition covers all of that group’s designated health services profits.

The word all matters. The agency explained that a group providing laboratory and diagnostic imaging services could not distribute laboratory profits to one subset of physicians and imaging profits to another subset on a service-by-service basis. The qualifying component’s profits from those services must be pooled before distribution, and each physician’s share cannot directly follow that physician’s referrals.

These group-practice rules matter to the in-office ancillary services exception that practices use for their own lab services. A broken profit-sharing formula can put the group’s ability to bill Medicare for those referrals at issue. For a finance employee, the contents of the pool matter alongside the formula used to divide it.

The alleged compensation periods in the Physician Partners of America and Northwest cases ended before these group-profit changes. Those cases show what the earlier arrangements counted: testing profit attributed to physicians and lab referrals after deductions.

The Separate Physician Settlement in the FISH-Testing Case

The FISH-testing case produced a corporate settlement and a separate obligation for an employed urologist. The Justice Department announced that 21st Century Oncology agreed to pay $19.75 million in December 2015 to resolve allegations of unnecessary tests billed to Medicare and TRICARE. It alleged that the company encouraged four urologists to order those tests through bonuses based partly on the number referred to its laboratory.

The following month, the government announced the urologist’s separate $1,050,000 settlement. The physician practiced with Naples Urology Associates, a division of 21st Century Oncology. After becoming a company employee in January 2010, he allegedly directed his FISH testing to its laboratory and received bonuses based partly on his referrals.

FISH, short for fluorescence in situ hybridization, tests urine for genetic abnormalities associated with bladder cancer. The government described Medicare coverage for monitoring a known bladder cancer’s return, or investigating suspected cancer after a full workup of a patient with blood in the urine. The alleged connection between test results and further testing is what makes the assistant’s account consequential.

The whistleblower was a former medical assistant who worked directly for the physician. Her complaint alleged that original negative urine results contradicted trace or positive results entered in the electronic record. In describing the records she had seen, she alleged:

That allegation connects the original result, the justification for ordering another test and the referral that could affect a bonus. It gives the medical necessity question a specific record comparison. The government announced that the assistant would receive $3.2 million from the company’s settlement, plus a separate share from the physician’s settlement.

What Evidence Does a Whistleblower Need?

Evidence of a referral-based laboratory bonus connects the compensation calculation to the orders, laboratory revenue and government claims that feed it. We examine the agreement alongside the actual calculation, including which physician receives credit for each order and which costs or fees come out before payment. Northwest shows why the billing company’s instructions belong beside the contract.

The clinical records answer another part of the question. The FISH complaint compared original results with the electronic chart, while the Physician Partners of America allegations addressed testing ordered without reviewing initial results. These comparisons put the reason for the test beside the money earned from it.

The company’s corporate integrity agreement with the Health and Human Services inspector general required reviews of testing patterns by ordering provider. It also required scrutiny of providers who had not regularly reviewed results and acted on them to modify patient care. That is a useful clinical counterpart to the financial calculation: what did the ordered test change for the patient?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you know how the bonus was calculated or why the testing was ordered, we can work through those connections with you. The person who understands the calculation and the person who saw the clinical record may each hold a part of the explanation.

When You Know What Earned the Bonus

If you know which orders fed a laboratory bonus or how the testing records changed, speak with our whistleblower experts about the arrangement. We work beside you to build your strongest case around the compensation decisions, clinical records and government payments, and bring in healthcare fraud whistleblower lawyers who understand physician compensation. We stay beside you through the process, from understanding the bonus formula to pursuing the case with the right whistleblower lawyers.